It is the short-cut for sure.
FDA dont usually suggest a Ph2b/3 right after Ph1b/2a, given the sample size of RAD101 trial history.
Sometimes they still require a complete Ph2 to test on patient in different doses.
- Forums
- ASX - By Stock
- Ann: FDA Pre-IND meeting supports an IND application for RAD 101
It is the short-cut for sure. FDA dont usually suggest a Ph2b/3...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAD (ASX) to my watchlist
|
|||||
Last
3.6¢ |
Change
-0.001(2.70%) |
Mkt cap ! $38.06M |
Open | High | Low | Value | Volume |
3.5¢ | 3.6¢ | 3.4¢ | $100.3K | 2.858M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 700000 | 3.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 245162 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700000 | 0.035 |
7 | 2385554 | 0.034 |
3 | 1016000 | 0.033 |
2 | 240000 | 0.032 |
5 | 292255 | 0.031 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 245162 | 4 |
0.039 | 391931 | 2 |
0.040 | 630704 | 5 |
0.041 | 164710 | 2 |
0.042 | 425000 | 1 |
Last trade - 15.54pm 20/08/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online